# Administrating Oxytocin to Treat Treatment Schizophrenia and Schizo-affective Patients

> **NCT01598623** · PHASE2 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 48 (estimated)

## Conditions studied

- Oxytocin + Non Specific Counselling
- Oxytocin + Social Skills Training
- Placebo + Non Specific Counselling
- Placebo + Social Skills Training

## Interventions

- **DRUG:** Oxytocin
- **BEHAVIORAL:** Social Skills Training
- **BEHAVIORAL:** Placebo + Non Specific Counselling

## Key facts

- **NCT ID:** NCT01598623
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2014-02
- **Final completion:** 2014-09
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2013-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01598623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01598623, "Administrating Oxytocin to Treat Treatment Schizophrenia and Schizo-affective Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01598623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*